Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 158,134 | 132,469 | 172,227 | 115,694 | 164,186 |
| Marketable Securities | 142,669 | 168,714 | 188,045 | 208,087 | 233,302 |
| Receivables | 66,761 | 59,938 | 70,938 | 69,340 | 55,768 |
| Inventories | 51,710 | 49,833 | 65,545 | 51,520 | 38,578 |
| TOTAL | $429,091 | $422,500 | $512,649 | $457,018 | $498,578 |
| Non-Current Assets | |||||
| PPE Net | 126,650 | 122,473 | 111,584 | 109,081 | 112,520 |
| Intangibles | 285,208 | 296,253 | 285,356 | 282,398 | 306,639 |
| Other Non-Current Assets | 63,999 | 66,211 | 57,151 | 61,929 | 73,378 |
| TOTAL | $475,857 | $484,937 | $454,091 | $453,408 | $492,537 |
| Total Assets | $904,948 | $907,437 | $966,740 | $910,426 | $991,115 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 31,237 | 32,004 | 28,489 | 27,509 | 31,686 |
| Accrued Expenses | 87,267 | 89,081 | 84,705 | 81,936 | 74,819 |
| TOTAL | $125,785 | $129,155 | $122,693 | $122,341 | $118,056 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | N/A | 1,000 | 1,000 |
| Other Non-Current Liabilities | 45,211 | 45,096 | 44,220 | 44,365 | 66,389 |
| TOTAL | $76,876 | $79,794 | $76,182 | $77,680 | $99,604 |
| Total Liabilities | $202,661 | $208,949 | $198,875 | $200,021 | $217,660 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 396,968 | 361,854 | 333,934 | 327,877 | 304,781 |
| Common Shares | 16 | 14 | 14 | 13 | 13 |
| Retained earnings | -2,703,626 | -2,612,373 | -2,500,715 | -2,384,552 | -2,305,993 |
| Other shareholders' equity | 16,103 | 20,859 | 6,294 | -1,046 | 16,242 |
| TOTAL | $702,287 | $698,488 | $767,865 | $710,405 | $773,455 |
| Total Liabilities And Equity | $904,948 | $907,437 | $966,740 | $910,426 | $991,115 |